---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-123805"
form_type: "8-K"
ticker: "TRDA"
cik: "0001689375"
company_name: "Entrada Therapeutics, Inc."
filed_at: "2023-12-06T23:59:59+00:00"
generated_at: "2026-06-07T17:13:27.467130+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Director John F. Crowley resigns from Entrada board; Chapman and Parmar fill committee vacancies

## Summary
- John F. Crowley resigned from Board, Audit Committee, and as Chair of Compensation Committee, effective December 5, 2023.
- Resignation not due to any disagreement with the Company's operations, policies, or practices.
- Board appointed Gina Chapman to Audit Committee and Kush M. Parmar, M.D., Ph.D. as member and Chair of Compensation Committee.

## SEC filing metadata
- accession: 0001104659-23-123805
- form_type: 8-K
- ticker: TRDA
- cik: 0001689375
- company_name: Entrada Therapeutics, Inc.
- filed_at: 2023-12-06T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1689375/000110465923123805/0001104659-23-123805-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1689375/000110465923123805/tm2332272d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-123805
- JSON: https://secwatch.observer/filing/0001104659-23-123805.json
- Plain text: https://secwatch.observer/filing/0001104659-23-123805.txt

## Key facts
- Executive change
  John F. Crowley resigned as member of the Board of Directors at Entrada Therapeutics, Inc..
  - Action: resigned
  - Role: member of the Board of Directors
  source text: On December 5, 2023, John F. Crowley, a member of the Board of Directors (the “Board”) of Entrada Therapeutics, Inc. (the “Company”), notified the Company of his resignation from the Board, including the Audit Committee of the Board (the “Audit Committee”), on which he serves as a member, and the Compensation Committee of the Board (the “Compensation Committee”), on which he serves as the Chair, effective December 5, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1689375/000110465923123805/0001104659-23-123805-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.